{"schema_version":"1","generated_at":"2026-11-16T17:11:43.910Z","data_as_of":null,"url":"https://www.findmykol.com/kol/prem-khilanani","json_url":"https://www.findmykol.com/kol/prem-khilanani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"prem-khilanani","name":"Prem Khilanani","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Beaumont Hospital","institution_url":"https://www.findmykol.com/institution/beaumont-hospital","city":"Troy","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1790857621","openalex":"A5075891329"},"summary":"Prem Khilanani is an Oncology physician affiliated with Beaumont Hospital. OpenAlex indexes 21 publications with 461 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":21,"cited_by_count":461,"h_index":11,"latest_activity_year":2011,"source":"works"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Bicalutamide","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":21,"shown":5,"withheld":16,"matched_by":"OpenAlex author record","recent":[{"title":"Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer","year":2011,"journal":"Radiotherapy and Oncology","source_url":"https://doi.org/10.1016/j.radonc.2011.05.038","status":"verified"},{"title":"Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreatic cancer.","year":2011,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2011.29.4_suppl.287","status":"verified"},{"title":"Improved Survival with Involved Field Radiotherapy and Concurrent Full Dose Gemcitabine for Unresectable Pancreatic Adenocarcinoma - The Eleven Year Beaumont Experience","year":2010,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2010.07.267","status":"verified"},{"title":"The Association of Autoimmune Thrombocytopenia and Hodgkin’s Disease","year":2009,"journal":"Oncology","source_url":"https://doi.org/10.1159/000224820","status":"verified"},{"title":"Comparison of Circulating Colony-Forming Cells in Chronic Granulocytic Leukemia and Leukemoid Reaction","year":2009,"journal":"Acta Haematologica","source_url":"https://doi.org/10.1159/000206916","status":"verified"}],"source":"works"},"contact":{"address_1":"44199 DEQUINDRE RD","address_2":"STE G10","city":"Troy","state":"MI","zip":"48085","phone":"248-964-6111","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790857621","source":"identity"},"similar":[{"name":"John Patrick Burke","slug":"john-burke-ie","institution":"Beaumont Hospital","url":"https://www.findmykol.com/kol/john-burke-ie","json_url":"https://www.findmykol.com/kol/john-burke-ie/profile.json"},{"name":"Michael G. Irwin","slug":"michael-irwin-ie","institution":"Beaumont Hospital","url":"https://www.findmykol.com/kol/michael-irwin-ie","json_url":"https://www.findmykol.com/kol/michael-irwin-ie/profile.json"},{"name":"Daniel G. Healy","slug":"daniel-healy-ie","institution":"Beaumont Hospital","url":"https://www.findmykol.com/kol/daniel-healy-ie","json_url":"https://www.findmykol.com/kol/daniel-healy-ie/profile.json"},{"name":"Michelle Casey","slug":"michelle-casey","institution":"Beaumont Hospital","url":"https://www.findmykol.com/kol/michelle-casey","json_url":"https://www.findmykol.com/kol/michelle-casey/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":16}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}